程民研究员

生命科学学院

电子邮箱

瀚海星云BBS

CMI杂志

中国科学技术大学

首页教授风采教授风采

程民研究员

( 2020-05-26 )

程民 研究员，硕导，2020年加入免疫所。附属第一医院分子医学实验室副主任。2001年毕业于山东大学，获学士学位；2010年毕业于中国科学技术大学，获博士学位；2010年至2012年于中国科学技术大学从事博士后研究。主要研究成果发表Cancer Research、Aging Cell、Immunity & Ageing、Cellular & Molecular Immunology等杂志，申请并获得国家发明专利授权12项。2010年获得“中国科学院王宽诚博士后工作奖”，2015年获得“第十六届安徽青年科技奖”，2017年入选“第十一批安徽省学术和技术带头人后备人选”，先后获得安徽省科技二等奖两项。

主要研究兴趣：

肺脏区域免疫应答及其微生态调控；肿瘤细胞免疫治疗；循环肿瘤细胞检测新技术。

近期发表文章：

1. Yongyan Chen^{# *}, Xiaolei Hao, Ming Li, Zhigang Tian, Min Cheng^*. UGRP1-modulated MARCO⁺ alveolar macrophages contribute to age-related lung fibrosis, Immunity & Ageing, 2023, 20:14

2. Cheng Min^{# *}; Chen Yongyan; Huang Dake; Chen Wen; Xu Weiping; Chen Yin;Shen Guodong; Xu Tingjuan; Shen Gan; Tian Zhigang; Hu Shilian^*; Intrinsically altered lung-resident γδT cells control lung melanoma by producing interleukin-17A in the elderly, Aging Cell, 2020, 19(e13099).

3. Cui KL, Mei XY, Cheng M^*. Increased interleukin-17A-producing gammadeltaT cells predict favorable survival in elderly patients with LUAD and LUSC. J Cancer Res Clin Oncol 2021.

4. Cui KL^{# *}, Hu SX^#, Mei XY, Cheng M^*. Innate Immune Cells in the Esophageal Tumor Microenvironment. Front Immunol 2021;12:654731.

5. Shouxin Hu, Yanfang Zha, Wenwen Yang, Kele Cu^* , and Min Cheng^*. Dysregulation of NK and CD8+T Cells by the Microbiota Promotes the Progression of Lung Cancer. Journal of Immunology Research. Volume 2022, Article ID 7057089.

6. Xinyu Mei#, Huan Li, Xinpeng Zhou, Min Cheng*, Kele Cui*. The emerging role of tissue-resident memory CD8+T lymphocytes in human digestive tract cancers. Frontiers in Oncology.2022

7. Cheng M^#*, Chen YY, Wang L, Chen W, Yang L, Shen GD, Xu TJ, Shen G, Tian ZG, Hu SL*. Commensal microbiota maintains alveolar macrophages with a low level of CCL24 production to generate anti-metastatic tumor activity. Scientific Reports. 2017,7:7471.

8. Cheng M^#*, Hu SL *. Lung-resident γδT cells and their roles in lung diseases. Immunology.2017,151:375-384.

9. Cheng M^#, Qian LT, Shen GD, Bian G, Xu TJ, Xu WP, Shen G, Hu SL*. Microbiota modulate tumoral immune surveillance in lung through a γδT17 immune cell-dependent mechanism. Cancer Research. 2014, 74(15):4030-4041.

10. Cheng M^#, Chen YY, Zou DH*, Shen GD, Bian G, Shen G, Hu SL*. The clinical utility of circulating tumor cells in breast cancer patients: detection by a quantitative assay of h-MAM gene expression.Int J Biol Markers.2014,29 (3): e268-e278.

11. Cheng M^#, Chen YY, Xiao WH, Sun R, Tian ZG*. NK cell-based immunotherapy for malignant diseases. Cellular & Molecular Immunology. 2013,10(3):230-252.

12. Cheng M^#, Fei BZ, Zheng XD, Chen YY, Sun R, Wei HM, Tian ZG*. A new reliable bioassay for determining the biological activity of human interleukin-12 by using human NK cell line NKG cells. International Immunopharmacology. 2012,13: 109–113.

13. Cheng M^#, Zhang J, Jiang W, Chen YY, Tian ZG*. Natural killer cell lines in tumor immunotherapy. Frontiers of Medicine. 2012, 6(1): 56–66.

14. Cheng M^#, Ma J, Chen YY, Zhang JH, Zhao WD, Zhang J, Wei HM, Ling B, Sun R, Tian ZG*.Establishment, Characterization and Successful Adaptive Therapy against Human Tumors of NKG Cell, a New Human NK Cell Line.Cell Transplantation. 2011, 20, 1731–1746.

15. Cheng M^#, Chen YY, Yu XQ, Tian ZG, Wei HM*. Diagnostic utility of LunX mRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer. BMC Cancer2008, 8:156.